NantKwest, Inc. Note Agreements

21 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantMobile, LLC
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2021
Amended and Restated Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated December 29, 2023
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2024
Letter Amendment dated December 29, 2023 to the Convertible Promissory Notes dated March 31, 2023 (as amended on September 11, 2023) and September 30, 2023 issued by ImmunityBio,...
Note Agreements
NantKwest, Inc.
Biotechnology
2024
Convertible Promissory Note dated
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2023
Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated June 1
Note Agreements
NantKwest, Inc.
Biotechnology
DE
2023
Convertible Promissory Note by and between the Company and Nant Capital, LLC dated as of March 31, 2023
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2023
Promissory Note between the Company and Nant Capital, LLC dated December 12, 2022
Note Agreements
NantKwest, Inc.
Biotechnology
DE
2022
Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantMobile, LLC dated August 31, 2022
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantCancerStemCell, LLC dated August 31, 2022
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and NantWorks, LLC dated August 31, 2022
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
Second Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
Amended and Restated Convertible Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
Amended and Restated Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2022
Promissory Note between ImmunityBio, Inc. and Nant Capital, LLC dated August 31, 2022
Note Agreements
NantKwest, Inc.
Biotechnology
DE
2022
Promissory Note by and between the Company and Nant Capital, LLC dated as of December 17, 2021
Note Agreements
NantKwest, Inc.
Biotechnology
DE
2021
Promissory Note, dated February 22, 2021, issued by NantCell, Inc. (f/k/a ImmunityBio, Inc.) to Nant Capital, LLC
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2021
Promissory Note, dated September 30, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2021
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantCancerStemCell, LLC
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2021
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to NantWorks, LLC
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2021
Amended and Restated Promissory Note, dated July 28, 2020, issued by ImmunityBio, Inc. to Nant Capital, LLC
Note Agreements
NantKwest, Inc.
Biotechnology
CA
2021